Open

Advanced Melanoma Treatment Study

In this study, we want to find a better treatment for advanced melanoma. We want to see how well two different drugs work compared to the regular treatment.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina (Statewide)

What will be asked of you

You will meet with the study team to fill out forms and go through a screening process. The study also involves tests and willingness to receive study treatment.

Incentives

You may be reimbursed reasonably for your travel costs to the site, including parking and any meals. This includes expenses for an accompanying caregiver or family member.

In-person visits:
Up to 36, dependent on study arm assignment

Phone or online visits:
12

Total length of participation:
5 years (60 months)

Looking for Specific Volunteers

Able to participate:

You have advanced melanoma with a BRAF V600 mutation status that has not responded to prior treatment
You have have had less than or equal to 2 lines of prior therapy

Not eligible if:

You have an acute or chronic Hepatitis B infection, HIV infection, active herpetic infections or HSV-1 infection
You have had another cancer in addition to melanoma within the last 3 years, except for locally curable cancers that have apparently been cured
You have an autoimmune disease requiring systemic treatment
You are currently participating in another clinical trial involving an investigational treatment.

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Lineberger Clinical Research
cancerclinicaltrials@med.unc.edu

Primary Visit Location

NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Frances Collichio
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Melanoma)

IRB Number

24-0591

ClinicalTrials.gov

NCT06264180

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.